Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: J Patient Saf. 2022 Jan 19;18(4):302–309. doi: 10.1097/PTS.0000000000000923

Table 2. Unadjusted Analysis.

Unadjusted univariate associations of patient characteristics, process outcomes, and primary mortality outcomes with telehealth utilization.

No Telehealth Use N = 1684
Mean/Median or N (%)
Telehealth Use N = 69
Mean/Median or N (%)
p-value
Facility:
A 790 (46.9%) 44 (63.8%) <0.01
B 894 (53.1%) 25 (36.2%)
Transfer for admission (yes vs no) 1360 (18.0%) 20 (71.0% 0.05
Patient Characteristics:
Age 71.0 73.0 0.69
Female 48.3% 47.8% 0.93
Infectious Source
 Urine 32.7% 27.5% 0.37
 Lung 38.1% 49.3% 0.06
 Intra-abdominal 10.2% 8.7% 0.84
 Unknown 14.1% 20.3% 0.15
SOFA Score 3.0 3.0 0.09
Process of Care Outcomes:
Sepsis Bundle
 Lactic Acid 96.5% 98.6% 0.73
 Blood Cultures 90.1% 89.9% 0.84
 Antibiotics 79.5% 78.3% 0.80
 IV Fluid* (N=516) 50.0% 58.8% 0.32
 Repeat Lactic Acid* (N=1192) 63.8% 78.0% 0.04
 Vasopressors* (N=295) 55.0% 63.6% 0.51
 Reassessment for Septic Shock* (N=488) 1.5% 11.1% <0.01
Primary Outcomes:
Inpatient Mortality 10.2% 8.7% 0.84
30-Day Mortality 19.5% 18.8% 0.89
*

Only includes patients for which this bundle component was required